A prospective, multicenter cancer clinical trial by the ECOG-ACRIN Cancer Research Group (ECOG-ACRIN) has validated an improved method for predicting treatment benefits in patients with hormone receptor-positive (HR+) metastatic breast…
(MedPage Today) -- SAN ANTONIO -- The antibody-drug conjugate (ADC) sacituzumab govitecan (Trodelvy) failed to outperform chemotherapy as first treatment after endocrine therapy for metastatic hormone receptor-positive/HER2-negative breast…
Preoperative radiation improved T-cell infiltration (TCI) in patients with hormone receptor (HR)-positive, HER2-negative breast cancer when administered in combination with pembrolizumab (Keytruda) and chemotherapy and led to improved…
Skipping sentinel lymph node biopsy (SLNB) in patients with clinically node-negative, hormonal receptor (HR)-positive, HER2-negative early-stage breast cancer did not compromise regional control or survival after a median five years of…
Roche's giredestrant cut recurrence risk by 30% in the phase 3 lidERA study, showing strong benefits in early ER-positive breast cancer with a consistent safety profile.
(MedPage Today) -- SAN ANTONIO -- Adding tucatinib (Tukysa) to first-line maintenance therapy with trastuzumab and pertuzumab (Perjeta) significantly improved progression-free survival (PFS) in patients with HER2-positive metastatic breast…
Routine mammograms are a critical tool for breast cancer screening. However, they may also hold crucial, potentially untapped information about a person's risk for cardiovascular disease, the number one cause of death among adults. The X…
WASHINGTON—U.S. Senator John Boozman (R-AR), a senior member of the Senate Committee on Veterans’ Affairs, joined committee Ranking Member Richard Blumenthal (D-CT), Chairman Jerry Moran (R-KS) and Senator Mazie Hirono
In October, TSG Hoffenheim brought the issue of breast cancer to the forefront and raised awareness with campaigns at home games of the women's and men's Bundesliga teams and the U23 team in the 3. Liga. A fundraising campaign was run in…
Skipping sentinel lymph node biopsy (SLNB) in patients with clinically node-negative, hormonal receptor (HR)-positive, HER2-negative early-stage breast cancer did not compromise regional control or survival after a median five years of…
Patients with stage 1 or 2, hormone receptor (HR)-negative breast cancer had similar five-year rates of locoregional recurrence whether or not they underwent preoperative breast magnetic resonance imaging (MRI) in addition to diagnostic…
Preoperative radiation improved T-cell infiltration (TCI) in patients with hormone receptor (HR)-positive, HER2-negative breast cancer when administered in combination with pembrolizumab (Keytruda) and chemotherapy and led to improved…
Get latest articles and stories on Business at LatestLY. Hyderabad (Telangana) [India], December 11: Pinkathon, India's biggest women's run, today announced the 6th edition of Pinkathon Hyderabad, joining hands with global innovation-led…
Julia Louis-Dreyfus revealed on Amy Poehler’s “Good Hang” podcast that she felt “backed into a corner” when she publicly disclosed her breast cancer diagnosis in 2017. At the time, HBO’s “Veep” was preparing for its seventh and final…
British scientists have developed a pioneering blood test to boost survival chances by quickly identifying breast cancer types so patients can quickly be put on the best treatment